Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIVEP zinc finger 1 (HIVEP1) is a large transcription factor from the ZAS protein family, characterized by multiple zinc finger domains, including widely spaced pairs of C2H2-type fingers and a distinct central zinc finger[1][2][5]. This protein binds specifically to the DNA kappa-B motif (5'-GGGACTTTCC-3'), which is present in enhancer elements of several viral promoters—such as those of HIV-1—and in related sequences within enhancers of several cellular genes, including class I major histocompatibility complex (MHC), interleukin-2 receptor, and interferon-beta[1][2][4][5]. HIVEP1 thereby regulates the transcription of both viral and host genes, influencing immune responses, T-cell activation, and viral gene expression. Isoforms may also function in apoptosis, and dysregulation or genetic variants in HIVEP1 have associations with immune deficiency and neurodevelopmental disorders[1][4][5]. No direct interacting drugs, biomarkers, or specific safety/therapeutic concerns are currently established for HIVEP1 as a clinical target[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIVEP zinc finger 1 (HIVEP1).